Does MOGAMULIZUMAB Cause Decreased appetite? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Decreased appetite have been filed in association with MOGAMULIZUMAB (POTELIGEO). This represents 3.9% of all adverse event reports for MOGAMULIZUMAB.
17
Reports of Decreased appetite with MOGAMULIZUMAB
3.9%
of all MOGAMULIZUMAB reports
6
Deaths
7
Hospitalizations
How Dangerous Is Decreased appetite From MOGAMULIZUMAB?
Of the 17 reports, 6 (35.3%) resulted in death, 7 (41.2%) required hospitalization, and 2 (11.8%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for MOGAMULIZUMAB.
What Other Side Effects Does MOGAMULIZUMAB Cause?
Rash (59)
Disease progression (46)
Infusion related reaction (42)
Pyrexia (35)
Febrile neutropenia (29)
Erythema (28)
Pruritus (26)
Drug ineffective (24)
Constipation (22)
Death (21)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which MOGAMULIZUMAB Alternatives Have Lower Decreased appetite Risk?
MOGAMULIZUMAB vs MOGAMULIZUMAB-KPKC
MOGAMULIZUMAB vs MOLNUPIRAVIR
MOGAMULIZUMAB vs MOLSIDOMINE
MOGAMULIZUMAB vs MOMELOTINIB
MOGAMULIZUMAB vs MOMETASONE